pubmed.ncbi.nlm.nih.gov

Nonallergic angioedema: role of bradykinin - PubMed

Review

Nonallergic angioedema: role of bradykinin

M Bas et al. Allergy. 2007 Aug.

Abstract

Angioedema is an underestimated clinical problem. Many cases are nonallergic reactions, e.g. bradykinin-induced angioedema caused by genetic defects and angiotensin-converting enzyme (ACE) inhibitors. This difference is crucial for successful therapy, in particular when complete emergency care is not available. Five important forms of nonallergic angioedema can be distinguished: hereditary (HAE), acquired (AAE), renin-angiotensin-aldosterone system (RAAS)-blocker-induced (RAE), pseudoallergic angioedema (PAE) and idiopathic angioedema (IAE). Some angioedema are present in the larynx and may cause death. A vast majority of nonallergic angioedema are RAE, particularly those caused by ACE inhibitors. It appears important to emphasize that in patients with complete intolerance to RAAS-blockers, cessation of RAAS-blockers is likely to be associated with increased cardiovascular risk. Currently, there is no published algorithm for diagnosis and treatment. Angioedema is usually treated by a conservative clinical approach using artificial ventilation, glucocorticoids and antihistamines. Today, a plasma pool C1-esterase inhibitor (C1-INH) concentrate is the therapy of choice in HAE. The current pharmacotherapy of nonallergic angioedema is not satisfactory, thus requiring the identification of effective agents in clinical trials. Recently, several new drugs were developed: a recombinant C1-INH, a kallikrein inhibitor (ecallantide) and a specific bradykinin-B2-receptor antagonist (icatibant). According to currently available reports, these drugs may improve the treatment of kinin-induced angioedema.

PubMed Disclaimer

Cited by

Role of Endothelial G Protein-Coupled Receptor Kinase 2 in Angioedema.
Gambardella J, Sorriento D, Bova M, Rusciano M, Loffredo S, Wang X, Petraroli A, Carucci L, Mormile I, Oliveti M, Bruno Morelli M, Fiordelisi A, Spadaro G, Campiglia P, Sala M, Trimarco B, Iaccarino G, Santulli G, Ciccarelli M. Gambardella J, et al. Hypertension. 2020 Nov;76(5):1625-1636. doi: 10.1161/HYPERTENSIONAHA.120.15130. Epub 2020 Sep 8. Hypertension. 2020. PMID: 32895019 Free PMC article.
An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II.
Floccard B, Hautin E, Bouillet L, Coppere B, Allaouchiche B. Floccard B, et al. Core Evid. 2012;7:105-14. doi: 10.2147/CE.S24743. Epub 2012 Sep 27. Core Evid. 2012. PMID: 23055948 Free PMC article.
Management of upper airway edema caused by hereditary angioedema.
Farkas H. Farkas H. Allergy Asthma Clin Immunol. 2010 Jul 28;6(1):19. doi: 10.1186/1710-1492-6-19. Allergy Asthma Clin Immunol. 2010. PMID: 20667122 Free PMC article.
Hereditary Angioedema: Diagnosis, Clinical Implications, and Pathophysiology.
Sinnathamby ES, Issa PP, Roberts L, Norwood H, Malone K, Vemulapalli H, Ahmadzadeh S, Cornett EM, Shekoohi S, Kaye AD. Sinnathamby ES, et al. Adv Ther. 2023 Mar;40(3):814-827. doi: 10.1007/s12325-022-02401-0. Epub 2023 Jan 7. Adv Ther. 2023. PMID: 36609679 Free PMC article. Review.
Recurrent macroglossia requiring tracheostomy after haemorrhagic basal ganglia stroke.
Osoba MY, Schneider AL, Alexiev B, Matsuoka AJ. Osoba MY, et al. BMJ Case Rep. 2021 Jan 11;14(1):e238775. doi: 10.1136/bcr-2020-238775. BMJ Case Rep. 2021. PMID: 33431468 Free PMC article.

Nonallergic angioedema: role of bradykinin - PubMed